Substance / Medication

Pantoprazole sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis.
Antonios Kais, Aintabi Daniel, McNally Patricia et al. · Cancer Rep (Hoboken) · 2025
PMID: 40040340Meta-AnalysisFull text (PMC)
Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis.
Zhuang Qianjun, Chen Songfeng, Zhou Xuyu et al. · Am J Gastroenterol · 2024
PMID: 38345252Meta-Analysis
Vonoprazan is superior to lansoprazole for healing of severe but not mild erosive esophagitis: A systematic review with meta-analysis of randomized controlled trials.
Simadibrata Daniel Martin, Lesmana Elvira, Fass Ronnie · J Gastroenterol Hepatol · 2024
PMID: 38353152Meta-Analysis
Achalasia: laparoscopic Heller myotomy with fundoplication versus peroral endoscopic myotomy-a systematic review and meta-analysis.
Sobral Joana, Machado Miguel, Barbosa José Pedro et al. · Esophagus · 2024
PMID: 38775883Meta-AnalysisFull text (PMC)
Significant and distinct impacts of sleeve gastrectomy and Roux-en-Y gastric bypass on esophageal acid exposure, esophageal motility, and endoscopic findings: a systematic review and meta-analysis.
Valentini Dirceu F, Mazzini Guilherme S, Lazzarotto-da-Silva Gabriel et al. · J Gastrointest Surg · 2024
PMID: 38901554Meta-Analysis
Efficacy and safety of QingReJieDu therapy in preventing acute radiation esophagitis: A systematic review and meta-analysis.
Wang Jian, Qiu Dan, Dong Xinying et al. · Medicine (Baltimore) · 2024
PMID: 39654193Meta-AnalysisFull text (PMC)
Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis.
Witarto Andro Pramana, Witarto Bendix Samarta, Pramudito Shidi Laras et al. · Sci Rep · 2023
PMID: 37709957Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pantoprazole sodium (substance)
SNOMED CT
116510001
UMLS CUI
C0795650

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.